Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by blackjack0on Jan 12, 2020 8:21pm

182 Views

Post# 30544750

RE:RE:RE:RE:RE:RE:Heffalump and/or Woozle in the Room

Because of the way that tld1433 works, meaning it has the same action on all mammals I don't know how you can come to any other logical conclusion, the only way it will not work at 90 days is if there is human error. I am taking into account the procedure is far superior to that used on the first 4 patients in phase one . Also the first three were treated at a half dose and still came up clean at 90 days. I don't think I am being at all unrealistic. I have no medical expertise at all but I think I am understanding what I have read and also told by people in the know

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide